UK Markets open in 6 hrs 50 mins
NIKKEI 225
29,255.55 +40.05 (+0.14%) HANG SENG
26,136.02 +348.82 (+1.35%) GOLD FUTURES
1,782.10 -2.80 (-0.16%) DOW
35,609.34 +152.04 (+0.43%) BTC-GBP
47,605.92 +991.11 (+2.13%) CMC Crypto 200
1,543.36 +62.56 (+4.22%)
Alzamend Neuro, Inc. (ALZN)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2900+0.0200 (+0.88%)
At close: 4:00PM EDT
2.3400 +0.05 (+2.18%)
After hours: 07:51PM EDT
After hours: 07:51PM EDT
| Previous close | 2.2700 |
| Open | 2.2700 |
| Bid | 2.2800 x 3200 |
| Ask | 2.3400 x 2200 |
| Day's range | 2.2250 - 2.3400 |
| 52-week range | 2.2200 - 33.5500 |
| Volume | 1,168,268 |
| Avg. volume | 2,735,873 |
| Market cap | 194.489M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Alzamend Neuro Receives Positive Pre-IND Response from FDA for AL002, a Cell-Based Therapeutic Vaccine That Seeks to Restore the Ability of Patients’ Immunological System to Combat Alzheimer’s Disease
TAMPA, Fla., September 30, 2021--Alzamend Neuro Gets Positive FDA Pre-IND Response for AL002, a Therapeutic Vaccine that Seeks to Restore Patient's Immuno System to Combat Alzheimer's
- Simply Wall St.
Could The Alzamend Neuro, Inc. (NASDAQ:ALZN) Ownership Structure Tell Us Something Useful?
Every investor in Alzamend Neuro, Inc. ( NASDAQ:ALZN ) should be aware of the most powerful shareholder groups...
© 2021 Verizon Media. All rights reserved.
